Content governance for a regulated field team is a written set of rules that answers four questions about every sales asset: who owns it, who approved it and for which audience, which version is the live one, and when it expires. Most companies can answer those questions for the website. Far fewer can answer them for the deck a rep presented in a cath lab last Tuesday, because that deck left the building the moment it was downloaded.
That gap is the whole problem. A content management system governs what sits on a server. A field team's content governance has to follow the asset onto laptops, tablets, email threads and the phone a rep hands across a desk. This post lays out who should own what, how to keep one live version when content travels, what should trigger an expiry, and how to pull a piece back once it is already in the field.
Why is content governance harder for medical device and life science field teams?
Three reasons, and they compound.
The content is regulated after it leaves. For prescription drugs, FDA's Office of Prescription Drug Promotion counts sales representative presentations among the promotional communications it oversees, and its Bad Ad program invites clinicians to report presentations they believe are misleading. For devices, the Quality Management System Regulation, in force since February 2, 2026, covers labeling and incorporates ISO 13485, whose document control clause expects current versions at the point of use and obsolete documents kept out of circulation. A sell sheet with a retired indication is not a marketing embarrassment. It is a document control finding.
Enforcement is not theoretical. The Office of Prescription Drug Promotion issued five enforcement letters a year in 2023 and 2024, then released nearly 100 untitled and warning letters in a single week of September 2025, according to a Hall Render review of the year. Most of that wave targeted consumer advertising, but the message to promotional review teams was plain: the agency reads what you publish.
The volume outruns the controls. Forrester found that 65% of content goes unused because of findability, relevance and quality problems, and an earlier Forrester study reported that 62% of organizations have reps looking in six or more places to find an asset. Six places means six copies, and only one of them can be current.
For pharma, biotech and diagnostics teams, the cost of a governance failure lands on the promotional review committee that approved the original, which is why sales enablement for life science teams has to be built around control of the asset after approval, not just before it. Approval is the start of the content's life, not the end of your responsibility for it.
What does content governance mean for a field sales team?
Enterprise content governance is usually about a website or a digital asset library: taxonomy, metadata, brand standards. All of that matters, but a field team needs something narrower and stricter. Every asset a rep can show or send must carry four facts, and someone must be accountable for each one.
- Owner. The person who can answer "is this still right?" by name, not by department.
- Approval scope. What it was cleared for: which product, which indication or intended use, which audience (clinician, administrator, distributor, patient), which market.
- Live version. The one file that is current, and proof that every other copy has been replaced.
- Expiry. The date or event after which the asset must be reviewed or withdrawn.
If any of the four is missing, the asset is ungoverned no matter how carefully it was approved. The rest of this post works through them in turn.
Who owns what in a regulated content library?
The most common failure is shared ownership, which in practice means no ownership. Marketing thinks regulatory watches expiry dates. Regulatory thinks marketing does. Enablement assumes the library tool handles it. Nobody checks the distributor's shared drive. Write it down once, and make it specific.
| Asset type | Owner (keeps it right) | Approver (clears it) | Operator (publishes and retires) | Review cycle |
|---|---|---|---|---|
| Product presentations and detail aids | Product marketing manager | Medical, legal, regulatory review | Sales enablement | At every label or IFU change, and at least annually |
| Clinical evidence summaries | Medical affairs | Medical, legal, regulatory review | Sales enablement | When new data publishes, and at least every six months |
| Health economics and value analysis packs | Market access or HEOR lead | Legal and regulatory | Sales enablement | Annually, and at every price or contract change |
| Instructions for use, labeling, package inserts | Regulatory affairs | Quality and regulatory | Document control | Every revision, no exceptions |
| Training and certification content | Sales training lead | Medical and regulatory for claims | Enablement or LMS admin | At every product update |
| Distributor and channel materials | Channel marketing manager | Legal and regulatory, per market | Sales enablement | Quarterly, with a confirmed replacement at each distributor |
| Rep-created follow-up content | Not permitted, or the rep's manager if allowed | None (which is the point) | None | Audit quarterly for existence |
Two rows deserve a note. Distributor materials fail most often because the people presenting them do not work for you, so the review cycle needs a confirmation step, not just a new upload. Rep-created content is listed because it exists whether or not policy allows it; the decision is whether to forbid it or permit it within limits, and to audit for it either way.
How do you control versions when content lives on laptops?
Version control for a field team is not about numbering files. It is about making the current version the easiest one to find, and making the old version impossible to find. Five rules do most of the work.
One source, no downloads to keep. Reps present and share from a library that updates everywhere at once, so there is nothing on the laptop to go stale. The one version, everywhere principle is the core of modern sales content management, and it is the only version control that survives a rep who has not opened email in three days of travel.
Replace, never add. When a new version is approved, it takes the old file's place, keeps its position in the library, and inherits its links. Uploading "v3_FINAL" beside "v2_FINAL" is how a rep ends up presenting the wrong one with a clear conscience.
Approval scope travels with the file. A clinical summary cleared for surgeons must not be one tap away from a distributor, and a US piece must not surface in a market where the indication differs. Segmenting the library so reps see only what they are cleared to use is a governance control, not a convenience. The approach is covered in detail in how to segment sales content access by user group.
Make finding faster than hoarding. Reps keep local copies because the library is slow. If a rep can ask the library a question and get the approved answer with its source, the desktop folder of "good slides" stops growing. SoloFire built Spark AI for exactly this reason.
Keep the record. ISO 13485 wants control of records as well as documents. For promotional content, that means being able to show which version was live on a given date and who could reach it. A library that logs publish, replace and retire events gives you that record without a spreadsheet.
When should sales content expire?
A fixed review date on every asset is the minimum. Most governance failures, though, come from events, not calendars. Write the triggers down and assign each one to the owner from the table above.
| Trigger | What it affects | Action within |
|---|---|---|
| Label, IFU or indication change | Every asset that states the indication, contraindications, or intended use | Same day: withdraw. One week: replace. |
| New clinical data, yours or a competitor's | Evidence summaries, comparison claims, value packs | Review within two weeks; withdraw any claim the new data contradicts |
| Price, contract or reimbursement change | Value analysis packs, ROI models, proposals | Before the next quote goes out |
| Regulatory letter to you or a competitor on a similar claim | Any asset making the same type of claim | Review within one week |
| Rebrand, name change or acquisition | Everything with a logo on it | Replace on the effective date; purge old-brand copies within 30 days |
| Scheduled review date reached | The asset itself | Re-approve or retire within the review cycle |
| Asset shows zero field use for 180 days | The asset itself | Retire it. Unused content is unreviewed content. |
The last row surprises people. Content nobody uses feels harmless, but it is still approved, still findable, and still carries your name, and it is the content most likely to have slipped past a review because nobody was looking. Retiring it shrinks the surface you have to govern.
Expiry only works if the review that follows is fast. A six-week promotional review pushes owners to leave old content live rather than start the clock. The fixes for that queue are in MLR review process: why approved content stalls.
How do you pull content back once it is in the field?
This is the test of any governance program, and it is the step most companies have never rehearsed. Run it as a five-step drill and time it.
- Identify every copy. Library, offline caches, distributor portals, LMS attachments, email sends, printed stock. If the list has to be assembled from memory, the answer is already "we cannot."
- Withdraw at the source. Retire the file in the library so it disappears from every device that syncs with it, including offline copies the next time they connect.
- Kill the links. Content shared as a tracked link can be withdrawn after the send. Content shared as an attachment cannot. This single difference decides whether a recall takes an hour or a legal hold.
- Notify and confirm. Tell reps and distributors what was withdrawn and what replaces it, and require a confirmation from anyone who holds printed stock.
- Record it. Log what was withdrawn, when, by whom, and what proof of removal exists. If a reviewer or an inspector asks, this log is your answer.
Step three is where most field teams discover their exposure. A rep who emails a PDF has created a copy you can never retrieve, in a buyer's inbox you will never see. The same file sent as a link that opens in a controlled viewer can be replaced or revoked, and you can see who opened it and when. The practical mechanics of that control for device reps are in how to control sales content for medical device reps.
Content governance checklist for regulated field teams
Use this as the audit. If you can tick every box, your program is in good shape. If you cannot, the unticked boxes are the plan.
- Every asset in the field library has a named owner, an approval scope, and a review date visible to admins.
- Reps present and share from a single library; downloading for local storage is disabled or audited.
- New versions replace old ones in place and inherit their links. Nothing is uploaded beside its predecessor.
- Library access is segmented by role, product line and market, so no rep can reach content they are not cleared to use.
- Expiry triggers are written down and each has an owner and a response time.
- Content unused for 180 days is reviewed for retirement every quarter.
- External sharing happens through tracked links that can be withdrawn, not attachments.
- Distributors receive content through the same controlled library, and each replacement is confirmed, not just published.
- Publish, replace and retire events are logged with dates and names.
- A recall drill has been run in the last twelve months, and the time to full withdrawal is known.
What good looks like
A diagnostics company with 60 reps and a distributor network learns of a labeling update on a Monday morning. By noon, the regulatory owner has retired four affected assets in the library. Reps in the field see them disappear on their tablets, including the ones working offline who sync that evening. Every tracked link that contained the old files now opens the replacement. Two distributors confirm by email that printed stock has been pulled. On Friday, the review committee clears the updated versions, and they publish into the same slots. The log shows the whole sequence with timestamps. Nobody sent an all-hands email asking people to delete files, because there were no files to delete.
That is not a large program. It is four facts per asset, one library, replace-not-add, tracked links instead of attachments, and a drill. Most of the work is deciding, in writing, who owns what. Start with a one-page inventory: list your asset types, fill in the owner table for each, and mark the rows where nobody's name fits. Those blanks are where the next finding will come from.
Frequently asked questions
What is content governance in sales enablement?
It is the set of rules and roles that control sales content after it is approved: who owns each asset, what it was cleared for, which version is current, when it expires, and how it is withdrawn. For regulated industries it extends promotional review and document control into the field, onto the devices reps actually use.
Who should own content governance for a medical device sales team?
Ownership should sit with the person who can answer whether an asset is still accurate, usually a product marketing manager or medical affairs lead for each asset type. Regulatory approves, sales enablement operates the library, and compliance or quality audits. A single accountable owner per asset type matters more than which function it sits in.
How often should sales content be reviewed?
Set a fixed review date on every asset, at least annually and every six months for clinical claims. More important, define event triggers such as a label change, new clinical data, a pricing change or a regulatory letter, and assign each trigger an owner and a response time. Retire anything unused for 180 days.
Can you recall sales content that has already been sent to a customer?
Only if it was sent as a tracked link that opens in a controlled viewer, where the file can be replaced or revoked after the send. An attachment cannot be recalled. That difference is why governed field teams share links rather than files, and log every send.